Psychometric Testing of the Traditional Chinese Version of the Fear of Progression Questionnaire-Short Form in Cancer Survivors

2021 ◽  
pp. JNM-D-21-00022
Author(s):  
Hui Lin Cheng ◽  
Man Chung Li ◽  
Doris Yin Ping Leung
Keyword(s):  
Hong Kong ◽  
Cancer Survivors ◽  
Goodness Of Fit ◽  
Online Survey ◽  
Short Form ◽  
Cancer Recurrence ◽  
Chinese Version ◽  
Fear Of Cancer Recurrence ◽  
Validity And Reliability ◽  
Fear Of Progression

Background and PurposeFear of cancer recurrence (FCR) is a frequent psychological adverse effect among cancer survivors. This study aimed to test the psychometric properties of the Traditional Chinese version of the 12-item Fear of Progression Questionnaire-Short Form (FoP-Q-SF).MethodsAn online survey was conducted with 311 cancer survivors in Hong Kong. The factor structure, known-group validity, and internal consistency reliability were examined.ResultsThe values measuring validity is good, with acceptable goodness-of-fit indexes (RMSEA = 0.073, SRMR = 0.042, CFI = 0.954), moderate to large correlations with unmet needs (0.339.0.816), being female, younger, had completed treatment ≤ 2 years, and had undergone chemotherapy/radiotherapy scored significantly higher on the FoP-Q-SF. The Cronbach’s alpha of the scale was .922.ConclusionsHigh validity and reliability indicate the scale’s value in assessing FCR in Hong Kong cancer survivors.

scholarly journals Is a Brief Online Booklet Sufficient to Reduce Fear of Cancer Recurrence or Progression in Women With Ovarian Cancer?

2021 ◽  
Vol 12 ◽  
Author(s):  
Poorva Pradhan ◽  
Louise Sharpe ◽  
Phyllis N. Butow ◽  
Allan Ben Smith ◽  
Hayley Russell
Keyword(s):  
Ovarian Cancer ◽  
Medical History ◽  
Short Form ◽  
Cancer Recurrence ◽  
Demographic Characteristics ◽  
Fear Of Cancer Recurrence ◽  
Self Help ◽  
Fear Of Progression ◽  
Psychosocial Need ◽  
Fear Of Cancer

Background: Fear of cancer recurrence or progression (FCR/P) is a common challenge experienced by people living with and beyond cancer and is frequently endorsed as the highest unmet psychosocial need amongst survivors. This has prompted many cancer organizations to develop self-help resources for survivors to better manage these fears through psychoeducation, but little is known about whether they help reduce FCR/P.Method: We recruited 62 women with ovarian cancer. Women reported on their medical history and demographic characteristics and completed the Fear of Progression Questionnaire-Short Form (FoP-Q-SF). They then read a booklet on FCR specifically created for Ovarian Cancer Australia by two of the authors (ABS and PB). One week after reading the booklet, 50/62 women (81%) completed the FoP-Q-SF and answered questions about their satisfaction with the booklet.Results: More than half of the women (35/62; 56.5%) scored in the clinical range for FCR/P at baseline. Of the completers, 93% said that they would recommend the booklet to other women. Satisfaction with the booklet was relatively high (75.3/100) and more than two-thirds of women rated it as moderately helpful or better. However, FCR/P did not change significantly over the week following reading the booklet [t(49) = 1.71, p = 0.09]. There was also no difference in change in FCR/P between women in the clinical vs. non-clinical range on the FoP-Q. Women high in FCR/P rated the booklet as less helpful in managing FCR/P (r = −0.316, p = 0.03), but overall satisfaction with the booklet was not associated with degree of FCR/P (r = −0.24, p = 0.10).Conclusions: These results suggest that a simple online FCR booklet is acceptable to women with ovarian cancer and they are satisfied with the booklet, but, it was insufficient to change in FCR/P levels. These results suggest that such resources are valued by women with ovarian cancer, but more potent interventions are necessary to reduce FCR in this population.

scholarly journals Fears of COVID-19 and cancer recurrence related to work sustainability among male cancer survivors

2021 ◽  
Keyword(s):  
Cancer Survivors ◽  
Short Form ◽  
Healthcare Providers ◽  
Cancer Recurrence ◽  
Path Model ◽  
Fear Of Cancer Recurrence ◽  
Disease Stage ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
Fear Of Cancer

Purpose: Male cancer survivors represent an important at-risk population for COVID-19. The COVID-19 pandemic requires a global response for this most vulnerable population. This study purpose was to explore whether fear of COVID-19 and fear of cancer recurrence are related to the likelihood of remaining at work following treatment in male cancer survivors. Survivors and methods: A cross-sectional survey was used. Data were collected in China in May to June 2020. The Fear of COVID-19 Scale, Fear of Cancer Recurrence (FCR) Inventory-Short Form and work sustainability subscale of the Readiness for Return to Work Scale were completed by male cancer survivors. Results: A total of 121 employed male cancer survivors participated in this study. Fear of COVID-19 and fear of cancer recurrence were both negatively correlated with work sustainability (β = -0.11, and β = -0.19, respectively). Significant interaction effects between fear of COVID-19 and fear of cancer recurrence were observed (β = 0.46, P < 0.01). Advanced disease stage, undergoing radiation therapy and having recently completed cancer treatment were all factors related to lower work sustainability scores (β = -0.28, β = -0.15, and β = -0.17, respectively). The overall path model yielded a good fit: χ2/df = 1.12 (P = 0.24), RMSEA = 0.07, TLI = 0.98, CFI = 0.99, IFI = 0.92, and NFI = 0.96. Conclusion: Fear of COVID-19 is a mediator between fear of cancer recurrence and work sustainability among Chinese male cancer survivors. The findings also indicated that male cancer survivors with higher FCR levels reported less confidence in their ability to remain at work. This information can assist in the development of new interventions and educational programs for cancer survivors, healthcare providers and employers, to improve employees' ability to remain at work.

scholarly journals Perilla Oil and Bifidobacterium for Alleviating Fear of Cancer Recurrence in Breast Cancer Survivors: Study Protocol for a Three-Arm Phase II Randomized Controlled Study (POB Study)

2021 ◽  
Vol 4 (3) ◽  
pp. 46
Author(s):  
Yohei Sasaki ◽  
Mina Honyashiki ◽  
Takayuki Kinoshita ◽  
Akira Matsui ◽  
Ayako Nakashoji ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Survivors ◽  
Phase Ii ◽  
Study Protocol ◽  
Breast Cancer Survivors ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Randomized Controlled ◽  
Perilla Oil ◽  
Fear Of Cancer

The fear of cancer recurrence (FCR) is the most common and most severe unmet need among cancer survivors. Safe treatments for the FCR that are easily disseminated are greatly needed. Our primary aim is a preliminary evaluation of the efficacy and effect size of perilla oil, which is rich in omega-3 fatty acids, and Bifidobacterium, a probiotic, on FCR in breast cancer survivors after the completion of chemotherapy. This study has been planned as an exploratory clinical study (phase II) and will be conducted as a three-arm, 12-week parallel group, masked-rater randomized controlled trial. Fifteen participants will be randomized with 1:1:1 allocation to receive Bifidobacterium plus perilla oil, Bifidobacterium alone, or no intervention (control). Interventions will end within 12 weeks after the random allocation of each participant. The participants will be outpatients with invasive breast cancer aged 20 years or older whose chemotherapy was completed at least 6 months before registration; hormone therapy may be ongoing. The primary outcome will be severity of FCR at 12 weeks assessed by masked raters using the 4-item Concerns about Recurrence Scale concerning overall fear of recurrence. The study protocol for the current study is registered in the Japan Registry of Clinical Trials (jRCTs031200029).

scholarly journals The Persian Version of the Fear of Cancer Recurrence Inventory (FCRI): Translation and Evaluation of Its Psychometric Properties

2019 ◽  
pp. 174-180
Author(s):  
Fatemeh Sadat Bateni ◽  
Maryam Rahmatian ◽  
Ahmad Kaviani ◽  
Sebastian Simard ◽  
Mehdi Soleimani ◽  
...  
Keyword(s):  
Psychometric Properties ◽  
Internal Consistency ◽  
Concurrent Validity ◽  
Goodness Of Fit ◽  
Cancer Recurrence ◽  
Fear Of Cancer Recurrence ◽  
Retest Reliability ◽  
Persian Version ◽  
Fear Of Cancer ◽  
Test Retest Reliability

Background: This study aimed to translate and validate the Fear of Cancer Recurrence Inventory (FCRI) questionnaire into Persian and to investigate its psychometric properties. Methods: The FCRI was translated to Persian using a linguistic methodology according to WHO guidelines. A total of 450 breast cancer survivors who had the following inclusion criteria were included: time elapse of more than six months after the treatment prior to the study; absence ofobjective markers of recurrence, fluency in the Persian language, and signing the informed consent. Internal consistency was estimated with Cronbach's α coefficient and test-retest reliability with Interclass correlation.  Concurrent validity was estimated through Pearson’s correlation between the FCRI and Hospital Anxiety and Depression Scale (HADS). Principal component analysis (PCA) and confirmatory factor analysis (CFA) were employed to evaluate dimensionality. Results: The Persian version was acceptable for patients. The content validity index (CVI) was 0.80.  The instrument had good test-retest reliability (ICC= 0.96) and internal consistency (Cronbach’s α=0.86).  PCA and CFA indicated that the factor structure of the Persian version was similar to the original questionnaire and had acceptable goodness of fit.  Correlations between the FCRI and HADS was remarkable (r= 0.252 – 0.639), indicating acceptable concurrent validity. Conclusions: The Persian version of FCRI could be considered a good cross-cultural equivalent for the original English version. The questionnaire was a reliable and valid instrument in terms of internal consistency, test-retest reliability, and dimensionality.

Sign in / Sign up

Export Citation Format

Share Document